Belén Guerra-Carrillo to speak about Cognition, Learning and How to Conduct a 200,000-participant Study at the 2017 SharpBrains Virtual Summit

By Alvaro Fernandez | September 8, 2017

Proud to con­firm a new excel­lent Speak­er @ 2017 Sharp­Brains Vir­tu­al Sum­mit (Decem­ber 5–7th). Belén Guer­ra-Car­ril­­lo is an NSF fel­low and a doc­tor­al stu­dent at UC Berke­ley in Prof. Sil­via Bunge’s Build­ing Blocks of Cog­ni­tion Lab. She is par­tic­u­lar­ly inter­est­ed in the neur­al and cog­ni­tive mech­a­nisms that give rise to changes that occur as a result of…

Read More

Study issues warning: Opioid inhibitor naltrexone (often used to treat addictions) can reduce feelings of social connection

By Greater Good Science Center | August 15, 2017

_________ Sci­ence has long known that hav­ing pos­i­tive social con­nec­tion is impor­tant to a hap­py and healthy life. But less is under­stood about how our brains sup­port and encour­age con­nect­ing with oth­ers. While pri­or research has sug­gest­ed oxy­tocin plays a role in nur­tur­ing and trust­ing oth­ers, there­by strength­en­ing social bonds, many researchers also sus­pect that…

Read More

E‑Newsletter: Neuroimaging + machine learning can predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

By SharpBrains | June 27, 2017

_____ Time for Sharp­Brains’ June e‑newsletter, fea­tur­ing fas­ci­nat­ing sci­en­tif­ic find­ings, promis­ing assess­ments, ther­a­pies and brain health mon­i­tor­ing tools…and some fun opti­cal illu­sions :-) New research Study com­bines neu­roimag­ing with machine learn­ing to pre­dict, with 96% accu­ra­cy, whether high-risk 6‑month-old babies will devel­op autism spec­trum dis­or­der (ASD) by age 2 Cog­ni­tive Train­ing or Gingko Bilo­ba to pre­vent cog­ni­tive decline and…

Read More

Study combines neuroimaging with machine learning to predict, with 96% accuracy, whether high-risk 6‑month-old babies will develop autism spectrum disorder (ASD) by age 2

By SharpBrains | June 12, 2017

— A Sin­gle Brain Scan Has Been Used to Accu­rate­ly Pre­dict Autism at Just 6 Months Old (Sci­ence alert) “Researchers have used brain scans and arti­fi­cial intel­li­gence to spot dif­fer­ences in how key areas of infant brains syn­chro­nise, allow­ing them to accu­rate­ly pre­dict which babies would devel­op autism spec­trum dis­or­der (ASD) as a toddler…The research, led…

Read More

Next: Increasing neuroplasticity via neuroimaging-enhanced brain stimulation

By SharpBrains | March 31, 2017
apparatus

Today we high­light a very thought-pro­­vok­ing (pun intend­ed) patent by Advanced Neu­ro­mod­u­la­tion Sys­tems. (As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date) U.S. Patent No. 7,756,584: Meth­ods and appa­ra­tus for effec­tu­at­ing a last­ing change in a neur­al-func­­tion of a patient Assignee(s): Advanced Neu­ro­mod­u­la­tion Sys­tems, Inc. Inventor(s): W. Dou­glas Sheffield, Andrew…

Read More

Neuroimaging as a marketing tool: Key Neurotech Patent #2

By SharpBrains | February 1, 2017

As men­tioned, we are fea­tur­ing a foun­da­tion­al Per­va­sive Neu­rotech patent a day, from old­er to new­er by issue date. Today we are shar­ing a 2000 patent assigned to The Nielsen Com­pa­ny. U.S. Patent No. 6,099,319: Neu­roimag­ing as a mar­ket­ing tool Assignee(s): The Nielsen Com­pa­ny Inventor(s): Ger­ald Zalt­man, Stephen M. Koss­lyn Tech­nol­o­gy Cat­e­go­ry: Hybrid Issue Date: August 8, 2000 SharpBrains’…

Read More